HUTCHMED (China) (HCM) Free Cash Flow (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Free Cash Flow of $96.5 million for Q2 2021, up 200.69% year-over-year from $32.1 million in Q2 2020, and up 692.26% quarter-over-quarter from -$16.3 million in Q1 2021.
HUTCHMED (China) (HCM) Free Cash Flow (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Free Cash Flow for 4 consecutive years, with $96.5 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Free Cash Flow rose 200.69% year-over-year to $96.5 million; the TTM figure through Dec 2022 stood at $96.5 million (up 20.31% YoY), while the FY2025 annual figure was -$8.3 million, down 146.22% from the prior year.
- Free Cash Flow rose to $96.5 million in Q2 2021 per HCM's latest filing, from -$16.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $96.5 million in Q2 2021 and bottomed at -$141.5 million in Q4 2019.
- Historically, Free Cash Flow has averaged $6.1 million across 4 years, with a median of $7.0 million in 2018.
- Annual changes were most pronounced in 2019 — Free Cash Flow jumped 2011.86% — and 2021, when it sank 5039.09%.
- HUTCHMED (China)'s Free Cash Flow stood at $10.4 million in 2018, then sank by 1465.05% to -$141.5 million in 2019, then surged by 122.69% to $32.1 million in 2020, then soared by 200.69% to $96.5 million in 2021.
- Business Quant data shows HCM's Free Cash Flow at $96.5 million in Q2 2021, -$16.3 million in Q1 2021, and $32.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 96.53 Mn |
| Jun 30, 2021 | 96.53 Mn |
| Mar 31, 2021 | -16.30 Mn |
| Mar 31, 2021 | -16.30 Mn |
| Jun 30, 2020 | 32.10 Mn |
| Jun 30, 2020 | 32.10 Mn |
| Mar 31, 2020 | 330,000.00 |
| Mar 31, 2020 | 330,000.00 |
| Dec 31, 2019 | -141.49 Mn |
| Dec 31, 2019 | -141.49 Mn |
| Sep 30, 2019 | 35.25 Mn |
| Sep 30, 2019 | 35.25 Mn |
| Jun 30, 2019 | 3.61 Mn |
| Jun 30, 2019 | 3.61 Mn |
| Mar 31, 2019 | 30.28 Mn |
| Mar 31, 2019 | 30.28 Mn |
| Dec 31, 2018 | 10.37 Mn |
| Dec 31, 2018 | 10.37 Mn |
| Sep 30, 2018 | 1.67 Mn |
| Sep 30, 2018 | 1.67 Mn |